• Sectors we work in banner(2)

    Quick Reads

AI and Big Data continue to shape the future of life sciences, but what challenges do we face?

min read

AI has transformed many aspects of life sciences, playing a huge role in helping to analyse vast amounts of data more quickly than humans can and enabling us to improve efficiencies – from drug discovery to clinical decision-making, from optimised productivity through to personalised healthcare and automated disease diagnosis. All the time helping us to optimise innovation, improve efficiencies, build new tools and help regulators define the framework in which AI operates.  

As the volume of data being consumed by AI continues to grow exponentially, we need to remain cognisant of the challenges we face. 

One of the biggest hurdles is being able to adopt and implement the infrastructure and tools needed to run facilities using AI. Implementing that infrastructure can create significant additional costs and investment. It also needs to be maintained and supported in the right way to provide you with the necessary agility to continue transforming. Making sure you select the right vendor and solution and have the right contracts in place will play a big part in that. 

By its nature, AI in life sciences will access sensitive personal information. As more personal information gets collected there are inevitably more risks posed to our privacy. Whilst the underlying questions may be the same as where data is used in any technology (Is the data being used fairly, lawfully and transparently? Do people understand how their data is being used? How is data kept secure?), the stakes are raised in complex AI systems. Data protection regimes need to provide the appropriate framework to protect individuals whilst not stifling opportunity. Big data approaches were applied to track and identify Covid-19 infections across the globe throughout the pandemic – access to that data proved invaluable in many ways – we need to carefully consider what to learn from that.

Big data also brings complex governance issues to many organisations. Whilst gaining access to a high volume of data from various sources (website and social media interactions, remote-monitoring sensors, wearables, clinical visits, imaging and so on) is crucial to big data, many organisations are not yet designed to handle such volumes. Ensuring the integrity and security of your data is maintained is fundamental to opening up the opportunities it presents. 

It is important for us to think about AI and big data at the beginning of any research planning instead of acquiring data first and thinking later. If we are to take advantage of AI models at the same (or an accelerated) pace, these (and many other) challenges must be addressed head-on.

Our thinking

  • Charles Russell Speechlys advises BioMed Realty on two new lettings at the Babraham B960 Research Campus

    Lynsey Inglis

    News

    min read
  • Property Patter: Building BioHubs miniseries: Lichfields

    Sophie Willis

    Podcasts

  • Breaking new ground? News of significant life sciences letting at an office to lab conversion

    Georgina Muskett

    Quick Reads

    min read
  • Triple Play "Bid Fever": UK Tech's ability to scale and go global

    Mark Howard

    Quick Reads

    min read
  • Planning for life sciences: an update

    Sophie Willis

    Quick Reads

    min read
  • Estates Gazette quotes Lynsey Inglis on trends in life sciences real estate investment

    Lynsey Inglis

    In the Press

    min read
  • Labour's Life Sciences Planning Reform

    Rachael Davidson

    Quick Reads

    min read
  • So Keir we are - how will a Labour government affect (property) investment in healthcare

    Mark White

    Quick Reads

    min read
  • Planning and Life Sciences: the challenges and opportunities in the Golden Triangle

    Sophie Willis

    Quick Reads

    min read
  • London’s Knowledge Clusters: From Emerging to Maturing – Start Ups on the Global Stage?

    Lynsey Inglis

    Quick Reads

    min read
  • Charles Russell Speechlys hosts international arbitration event in Dubai

    Peter Smith

    Quick Reads

    min read
  • Re-purposing Retail - is life sciences the answer?

    Louise Ward

    Quick Reads

    min read
  • EU AI Act – Will it become a law for all the world?

    Quick Reads

    min read
  • Court of Appeal Confirms that Property Guardians Occupied an HMO

    Christopher Gothard

    Quick Reads

    min read
  • BE News quotes Louise Ward on the Autumn Statement and life sciences support

    Louise Ward

    In the Press

    min read
  • Office to Lab Conversions: A new lease of life (sciences) for some of London’s offices?

    Georgina Muskett

    Quick Reads

    min read
  • Pharmaphorum quotes Louise Ward on the Budget and what this means for the biopharma sector

    Louise Ward

    In the Press

    min read
  • Life Sciences blow as AZ snubs UK

    Louise Ward

    Quick Reads

    min read
  • EG quotes Louise Ward on the resilience of the life sciences sector in 2022

    Louise Ward

    In the Press

    min read
  • Life Sciences - Where Next?

    Fiona Edmond

    Quick Reads

    min read
Back to top